Moderna Inc. MRNA, -0.86% said late Wednesday that it vaccinated the first 60 people participating in a study meant to evaluate COVID-19 vaccine-booster candidates. That was out of "an abundance of caution" as previously published data has shown that its vaccine being currently administrated around the world has worked against all variants tested, including the U.K. and the South Africa strains, the company said. Shares of Moderna fell less than 0.1% in the extended session Wednesday after ending the regular trading day down 0.9%.
The Link LonkMarch 11, 2021 at 04:35AM
https://ift.tt/3eoTHE9
Moderna vaccinates first people in study to test vaccine-booster candidates - MarketWatch
https://ift.tt/2DVP6sH
No comments:
Post a Comment